BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 23703660)

  • 1. The -319C/+49G/CT60G haplotype of CTLA-4 gene confers susceptibility to rheumatoid arthritis in Mexican population.
    Torres-Carrillo N; Ontiveros-Mercado H; Torres-Carrillo NM; Parra-Rojas I; Rangel-Villalobos H; Ramírez-Dueñas MG; Gutiérrez-Ureña SR; Valle Y; Muñoz-Valle JF
    Cell Biochem Biophys; 2013; 67(3):1217-28. PubMed ID: 23703660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CTLA-4 and CD86 genetic variants and haplotypes in patients with rheumatoid arthritis in southeastern China.
    Liu CP; Jiang JA; Wang T; Liu XM; Gao L; Zhu RR; Shen Y; Wu M; Xu T; Zhang XG
    Genet Mol Res; 2013 Apr; 12(2):1373-82. PubMed ID: 23661460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease.
    Pawlak-Adamska E; Frydecka I; Bolanowski M; Tomkiewicz A; Jonkisz A; Karabon L; Partyka A; Nowak O; Szalinski M; Daroszewski J
    Endocrine; 2017 Jan; 55(1):186-199. PubMed ID: 27638540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The +1858C/T PTPN22 gene polymorphism confers genetic susceptibility to rheumatoid arthritis in Mexican population from the Western Mexico.
    Torres-Carrillo NM; Ruiz-Noa Y; Martínez-Bonilla GE; Leyva-Torres SD; Torres-Carrillo N; Palafox-Sánchez CA; Navarro-Hernández RE; Rangel-Villalobos H; Oregón-Romero E; Muñoz-Valle JF
    Immunol Lett; 2012 Sep; 147(1-2):41-6. PubMed ID: 22743847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The +49A>G CTLA-4 polymorphism is associated with rheumatoid arthritis in Mexican population.
    Muñoz-Valle JF; Valle Y; Padilla-Gutiérrez JR; Parra-Rojas I; Rangel-Villalobos H; Vázquez del Mercado M; Ledezma-Lozano IY; Villafan-Bernal JR; Armendáriz-Borunda J; Pereira-Suárez AL
    Clin Chim Acta; 2010 May; 411(9-10):725-8. PubMed ID: 20138855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A CT60G>A polymorphism in the CTLA-4 gene of the recipient may confer susceptibility to acute graft versus host disease after allogeneic hematopoietic stem cell transplantation.
    Karabon L; Markiewicz M; Partyka A; Pawlak-Adamska E; Tomkiewicz A; Dzierzak-Mietla M; Kyrcz-Krzemien S; Frydecka I
    Immunogenetics; 2015 Jun; 67(5-6):295-304. PubMed ID: 25940108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel multiplex pyrosequencing assay for genotyping functionally relevant CTLA-4 polymorphisms: potential applications in autoimmunity and cancer.
    Banelli B; Morabito A; Laurent S; Piccioli P; Dozin B; Ghio M; Ascierto PA; Monteghirfo S; Marasco A; Ottaviano V; Queirolo P; Romani M; Pistillo MP
    Hum Immunol; 2014 Aug; 75(8):730-9. PubMed ID: 24801647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTLA-4, CD28, and ICOS gene polymorphism associations with non-small-cell lung cancer.
    Karabon L; Pawlak E; Tomkiewicz A; Jedynak A; Passowicz-Muszynska E; Zajda K; Jonkisz A; Jankowska R; Krzakowski M; Frydecka I
    Hum Immunol; 2011 Oct; 72(10):947-54. PubMed ID: 21669243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to osteosarcoma.
    Liu Y; He Z; Feng D; Shi G; Gao R; Wu X; Song W; Yuan W
    DNA Cell Biol; 2011 Dec; 30(12):1051-5. PubMed ID: 21612409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble CTLA-4 receptor an immunological marker of Graves' disease and severity of ophthalmopathy is associated with CTLA-4 Jo31 and CT60 gene polymorphisms.
    Daroszewski J; Pawlak E; Karabon L; Frydecka I; Jonkisz A; Slowik M; Bolanowski M
    Eur J Endocrinol; 2009 Nov; 161(5):787-93. PubMed ID: 19734241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTLA-4 and CD28 genes' polymorphisms and renal cell carcinoma susceptibility in the Polish population--a prospective study.
    Tupikowski K; Partyka A; Kolodziej A; Dembowski J; Debinski P; Halon A; Zdrojowy R; Frydecka I; Karabon L
    Tissue Antigens; 2015 Nov; 86(5):353-61. PubMed ID: 26403483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haplotype analysis in simplex families and novel analytic approaches in a case-control cohort reveal no evidence of association of the CTLA-4 gene with rheumatoid arthritis.
    Barton A; Jury F; Eyre S; Bowes J; Hinks A; Ward D; Worthington J
    Arthritis Rheum; 2004 Mar; 50(3):748-52. PubMed ID: 15022315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of cytotoxic T-lymphocyte antigen-4 polymorphisms on acute rejection onset of cadaveric renal transplants.
    Canossi A; Aureli A; Delreno F; Iesari S; Cervelli C; Clemente K; Famulari A; Pisani F; Papola F
    Transplant Proc; 2013 Sep; 45(7):2645-9. PubMed ID: 24034013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic T lymphocyte associated antigen-4 (CTLA-4) +49 A>G gene polymorphism in Egyptian cases with rheumatoid arthritis.
    Elshazli R; Settin A; Salama A
    Gene; 2015 Mar; 558(1):103-7. PubMed ID: 25542810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The extrapituitary prolactin promoter polymorphism is associated with rheumatoid arthritis and anti-CCP antibodies in Mexican population.
    Reyes-Castillo Z; Pereira-Suárez AL; Palafox-Sanchez CA; Rangel-Villalobos H; Estrada-Chávez C; Oregón-Romero E; Angel-Chávez LI; Muñoz-Barrios S; Bueno-Topete MR; Muñoz-Valle JF
    Gene; 2013 Aug; 525(1):130-5. PubMed ID: 23660301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD28, CTLA-4 and CCL5 gene polymorphisms in patients with rheumatoid arthritis.
    Luterek-Puszyńska K; Malinowski D; Paradowska-Gorycka A; Safranow K; Pawlik A
    Clin Rheumatol; 2017 May; 36(5):1129-1135. PubMed ID: 27988812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of CTLA4 haplotypes on susceptibility and some extraglandular manifestations in primary Sjögren's syndrome.
    Downie-Doyle S; Bayat N; Rischmueller M; Lester S
    Arthritis Rheum; 2006 Aug; 54(8):2434-40. PubMed ID: 16869018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of CTLA-4 gene polymorphism with end-stage renal disease and renal allograft outcome.
    Misra MK; Kapoor R; Pandey SK; Sharma RK; Agrawal S
    J Interferon Cytokine Res; 2014 Mar; 34(3):148-61. PubMed ID: 24313821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional genetic variants of CTLA-4 and risk of tobacco-related oral carcinoma in high-risk North Indian population.
    Bharti V; Mohanti BK; Das SN
    Hum Immunol; 2013 Mar; 74(3):348-52. PubMed ID: 23246583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PADI4 polymorphisms and the functional haplotype are associated with increased rheumatoid arthritis susceptibility: A replication study in a Southern Mexican population.
    Baños-Hernández CJ; Navarro-Zarza JE; Parra-Rojas I; Vázquez-Villamar M; Ramón Padilla-Gutiérrez J; Valle Y; Reyes-Castillo Z; Magdalena Torres-Carrillo N; García-Arellano S; Brennan-Bourdon LM; Muñoz-Valle JF
    Hum Immunol; 2017 Sep; 78(9):553-558. PubMed ID: 28551357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.